Cargando…
Aspirin overcomes cisplatin resistance in lung cancer by inhibiting cancer cell stemness
BACKGROUND: Lung cancer is the leading cause of cancer death and is commonly treated by cisplatin. Although cisplatin treatment may initially be successful, its effectiveness usually reduces significantly in disease‐recurrent patients. Aspirin, a nonselective COX inhibitor, has been shown to help re...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley & Sons Australia, Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7605995/ https://www.ncbi.nlm.nih.gov/pubmed/32991066 http://dx.doi.org/10.1111/1759-7714.13619 |